Chenicheri Hariharan Nair
Geen lopende functies
Loopbaan van Chenicheri Hariharan Nair
Eerdere bekende functies van Chenicheri Hariharan Nair
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MEMPHASYS | Directeur/Bestuurslid | 22-06-2011 | 29-11-2013 |
| President | 16-10-2009 | 01-12-2012 | |
Arturus Capital Ltd.
 Arturus Capital Ltd. Financial ConglomeratesFinance Arturus Capital Ltd. is an investment company that holds interests in mining and gas projects. The company was founded on May 31, 1972 and is headquartered in North Perth, Australia. | Directeur/Bestuurslid | 01-01-2004 | 22-12-2007 |
PrIME Biologics Pte Ltd.
 PrIME Biologics Pte Ltd. BiotechnologyHealth Technology PrIME Biologics Pte Ltd. develops disposable therapeutic plasma manufacturing process. Its process doubles product yields while increasing product safety and removing viruses, bacteria, endotoxins, and prions. The firm’s process reduces the time it takes to produce multiple plasma products from days to hours. The company is headquartered in Singapore. | Voorzitter | - | - |
Opleiding van Chenicheri Hariharan Nair
| Australian National University | Doctorate Degree |
Statistieken
Internationaal
| Australië | 4 |
| Singapore | 2 |
Operationeel
| Director/Board Member | 2 |
| President | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MEMPHASYS | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Arturus Capital Ltd.
Arturus Capital Ltd. Financial ConglomeratesFinance Arturus Capital Ltd. is an investment company that holds interests in mining and gas projects. The company was founded on May 31, 1972 and is headquartered in North Perth, Australia. | Finance |
PrIME Biologics Pte Ltd.
PrIME Biologics Pte Ltd. BiotechnologyHealth Technology PrIME Biologics Pte Ltd. develops disposable therapeutic plasma manufacturing process. Its process doubles product yields while increasing product safety and removing viruses, bacteria, endotoxins, and prions. The firm’s process reduces the time it takes to produce multiple plasma products from days to hours. The company is headquartered in Singapore. | Health Technology |
